John A. Johnson, MD, MBA: The microvascular complications of diabetes include anything from effects on [a patient’s] blood pressure, peripheral neuropathy, the ability to have abnormalities in their sensation (in their hands and feet), and blindness. Macrovascular complications include cardiovascular effects such as heart attacks, stroke, and end-stage kidney disease.
So we look at ways that we can, in a preventative approach, reduce those complications because, as we’ve seen at WellCare, in patients who don’t have access to care—either inadequate access or lack of behavioral modification in lifestyle changes—a negative impact in their outcomes is seen.
We work with the provider community to make them aware of the members that they have within their care—that are WellCare members—and [figure out] how we can partner with them and equip them with tools to enhance the care of diabetics to prevent or delay the onset of these micro- and macrovascular complications.
Unmet Needs Remain in Secondary AML Following Treatment With HMAs
January 18th 2025The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated with hypomethylating agents (HMAs) for myeloid neoplasms such as myelodysplastic syndromes.
Read More
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More
Unmet Needs Remain in Secondary AML Following Treatment With HMAs
January 18th 2025The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated with hypomethylating agents (HMAs) for myeloid neoplasms such as myelodysplastic syndromes.
Read More
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More
2 Commerce Drive
Cranbury, NJ 08512